CORIX BIOSCIENCE, INC.
CIK 0001433821
Revenue (TTM)
$675.98K
+43.8% YoY
Q3 Nov 2017
Net Income (TTM)
−$4.5M
−60.1% YoY
Q3 Nov 2017
EPS Diluted (TTM)
—
Q3 Nov 2017
Gross Margin
—
Q3 Nov 2017
Operating Margin
-14.4%
Q3 Nov 2017
Net Margin
-665.0%
Q3 Nov 2017
Free Cash Flow (TTM)
—
Q3 Nov 2017
Cash
$120.41K
Q3 Nov 2017
Total Debt
$659.71K
Q3 Nov 2017
Shares Outstanding
24.87M sh
Q3 Nov 2017